nVerses Capital’s Biomea Fusion BMEA Stock Holding History

nVerses Capital’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100	Closed	-$1.01K	–	117
2024 Q3	$1.01K	Buy	+100	New	+$650	﹤0.01%	959

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

nVerses Capital's BMEA Position: Q4 2024 in Review

nVerses Capital sold out of Biomea Fusion (BMEA) in Q4 2024, closing a stake of 100 shares — an estimated $1.01K sold.

nVerses Capital first reported a position in BMEA in Q3 2024 and held it in 1 quarter. The position peaked at $1.01K in Q3 2024. 108 funds tracked by Wall St. Rank hold BMEA as of Q4 2024.

nVerses Capital reported no remaining Biomea Fusion position as of Q4 2024 after selling out during the quarter.
nVerses Capital sold 100 Biomea Fusion shares in Q4 2024, an estimated $1.01K.
nVerses Capital first reported a position in Biomea Fusion in Q3 2024 and held it in 1 quarter.
nVerses Capital's Biomea Fusion position peaked at $1.01K in Q3 2024.
108 funds tracked by Wall St. Rank held Biomea Fusion as of Q4 2024.

Based on nVerses Capital's 13F filing for Q4 2024.